PTCD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.025600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.693200E-01
Normal-vs-Stage2
4.611800E-01
Normal-vs-Stage3
4.929700E-02
Normal-vs-Stage4
8.453000E-01
Stage1-vs-Stage2
3.748200E-02
Stage1-vs-Stage3
1.119210E-03
Stage1-vs-Stage4
1.871780E-01
Stage2-vs-Stage3
6.934300E-02
Stage2-vs-Stage4
5.325000E-01
Stage3-vs-Stage4
5.566200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.409000E-01
Normal-vs-AfricanAmerican
4.076800E-01
Normal-vs-Asian
1.882400E-01
Caucasian-vs-AfricanAmerican
6.508200E-01
Caucasian-vs-Asian
4.146300E-02
AfricanAmerican-vs-Asian
4.251000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.814600E-01
Normal-vs-Female
5.391600E-01
Male-vs-Female
6.097400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.746200E-01
Normal-vs-Age(41-60Yrs)
8.197000E-01
Normal-vs-Age(61-80Yrs)
3.296800E-01
Normal-vs-Age(81-100Yrs)
7.260600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.940400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.135400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.090600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.106500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.654800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.842400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.518600E-01
Normal-vs-Daily Drinker
4.286400E-01
Normal-vs-Weekly Drinker
2.708800E-01
Normal-vs-Occasional Drinker
8.301600E-01
Normal-vs-Social Drinker
9.840600E-01
Non Drinker-vs-Daily Drinker
3.385200E-01
Non Drinker-vs-Weekly Drinker
9.764000E-01
Non Drinker-vs-Occasional Drinker
6.494100E-02
Non Drinker-vs-Social Drinker
2.793700E-02
Daily Drinker-vs-Weekly Drinker
4.051000E-01
Daily Drinker-vs-Occasional Drinker
3.139400E-01
Daily Drinker-vs-Social Drinker
1.511050E-01
Weekly Drinker-vs-Occasional Drinker
1.162380E-01
Weekly Drinker-vs-Social Drinker
5.616500E-02
Occasional Drinker-vs-Social Drinker
6.768200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.513000E-01
Normal-vs-Grade 2
8.080100E-02
Normal-vs-Grade 3
6.689800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.678400E-01
Grade 1-vs-Grade 3
9.149900E-02
Grade 1-vs-Grade 4
3.513000E-01
Grade 2-vs-Grade 3
3.631000E-01
Grade 2-vs-Grade 4
8.080100E-02
Grade 3-vs-Grade 4
6.689800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.631200E-01
Normal-vs-NonDiabetic
4.354200E-01
Diabetic-vs-NonDiabetic
6.200600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.213000E-01
Normal-vs-NoPancreatitis
4.438800E-01
Pancreatitis-vs-NoPancreatitis
8.258800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.102400E-01
Normal-vs-N1
4.702000E-01
N0-vs-N1
5.637000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.059400E-01
Normal-vs-TP53-NonMutant
9.019600E-01
TP53-Mutant-vs-TP53-NonMutant
2.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
